A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS)
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Pediatrics